Skip to main content

Sandesh Mahatme

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Sandesh Mahatme

Sandesh Mahatme was last confirmed as CFO at Sarepta Therapeutics, Inc. (SRPT) in a filing dated April 20, 2021. Earlier roles on record: CFO at Sarepta Therapeutics, Inc. (SRPT) until July 10, 2020. The proxy statement of Sarepta Therapeutics, Inc. reports total compensation of $3,364,021 for Sandesh Mahatme in fiscal 2020, including a base salary of $312,835. Disclosed compensation is on record for 4 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Sarepta Therapeutics, Inc. (SRPT) $312,835 $3,364,021
2019 Sarepta Therapeutics, Inc. (SRPT) $557,327 $5,161,209
2018 Sarepta Therapeutics, Inc. (SRPT) $498,112 $4,219,084
2017 Sarepta Therapeutics, Inc. (SRPT) $459,252 $2,200,133

Recent activity

No call appearances or filed executive changes recorded yet.